In this first study on the role of OPTN in experimental pancreatic cancer, it was tempting to reduce OPTN levels, which are generally increased in PDAC, by a knockdown strategy in order to investigate its value as therapeutic target. Here, OPTN is linked to familial pancreatic carcinoma.